Literature DB >> 25131217

Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention.

Anne C Moorman1, Jian Xing, Stephen Ko, Loralee B Rupp, Fujie Xu, Stuart C Gordon, Mei Lu, Philip R Spradling, Eyasu H Teshale, Joseph A Boscarino, Vinutha Vijayadeva, Mark A Schmidt, Scott D Holmberg.   

Abstract

UNLABELLED: To determine the stage of liver disease at initial diagnosis of hepatitis C virus (HCV) infection, we analyzed data from the Chronic Hepatitis Cohort Study (CHeCS), a large U.S. observational study. We examined the temporal relationships of initial HCV infection diagnosis with cirrhosis-defined by liver biopsy or mean FIB-4 score >5.88-and time to onset of cirrhotic decompensation in electronic medical records. We determined time in the health system prior to HCV diagnosis and rates of hospitalization and death following HCV diagnosis. Of 14,717 patients with chronic HCV seen during 2006-2011, 6,166 (42%) had a definable time of initial HCV diagnosis. Of these, 1,056 (17%) patients met our definition for "late diagnosis" with either cirrhosis concurrent with initial HCV diagnosis (n = 550), a first diagnosis of hepatic decompensation before or within 12 months after initial HCV diagnosis (n = 506), or both (n = 314). Patients with late diagnosis had an average of 6 years in the health system before their HCV diagnosis. In a comparison with patients without late diagnosis, hospitalization (59% versus 35%) and death (33% versus 9%) were more frequent among patients with late diagnosis. Among all who died, mean (median) time from initial HCV diagnosis to death was 4.8 (4.2) years.
CONCLUSION: Many CHeCS patients had advanced liver disease concurrent with their initial HCV diagnosis despite many years of engagement with the healthcare system, and these patients had high rates of hospitalization and mortality.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2015        PMID: 25131217      PMCID: PMC5675516          DOI: 10.1002/hep.27365

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  11 in total

Review 1.  Noninvasive methods to assess liver disease in patients with hepatitis B or C.

Authors:  Laurent Castera
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

2.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

Authors:  Richard K Sterling; Eduardo Lissen; Nathan Clumeck; Ricard Sola; Mendes Cassia Correa; Julio Montaner; Mark S Sulkowski; Francesca J Torriani; Doug T Dieterich; David L Thomas; Diethelm Messinger; Mark Nelson
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

3.  The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases.

Authors:  Michael Adler; Béatrice Gulbis; Christophe Moreno; Sylvie Evrard; Gontran Verset; Philippe Golstein; Brigitte Frotscher; Nathalie Nagy; Philippe Thiry
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

4.  Hepatitis C in the United States.

Authors:  Scott D Holmberg; Philip R Spradling; Anne C Moorman; Maxine M Denniston
Journal:  N Engl J Med       Date:  2013-05-16       Impact factor: 91.245

5.  Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection.

Authors:  Stuart C Gordon; Paul J Pockros; Norah A Terrault; Robert S Hoop; Ami Buikema; David Nerenz; Fayez M Hamzeh
Journal:  Hepatology       Date:  2012-10-09       Impact factor: 17.425

6.  Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study.

Authors:  Anne C Moorman; Stuart C Gordon; Loralee B Rupp; Philip R Spradling; Eyasu H Teshale; Mei Lu; David R Nerenz; Cynthia C Nakasato; Joseph A Boscarino; Emily M Henkle; Nancy J Oja-Tebbe; Jian Xing; John W Ward; Scott D Holmberg
Journal:  Clin Infect Dis       Date:  2012-09-18       Impact factor: 9.079

7.  Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma.

Authors:  Benjamin Yip; James M Wantuck; Lily H Kim; Robert J Wong; Aijaz Ahmed; Gabriel Garcia; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2013-11-27       Impact factor: 3.199

8.  Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.

Authors:  Scott D Holmberg; Mei Lu; Loralee B Rupp; Lois E Lamerato; Anne C Moorman; Vinutha Vijayadeva; Joseph A Boscarino; Emily M Henkle; Stuart C Gordon
Journal:  Clin Infect Dis       Date:  2013-04-16       Impact factor: 9.079

9.  The validity of serum markers for fibrosis staging in chronic hepatitis B and C.

Authors:  J Li; S C Gordon; L B Rupp; T Zhang; J A Boscarino; V Vijayadeva; M A Schmidt; M Lu
Journal:  J Viral Hepat       Date:  2014-01-29       Impact factor: 3.728

10.  Locations and reasons for initial testing for hepatitis C infection--chronic hepatitis cohort study, United States, 2006-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-08-16       Impact factor: 17.586

View more
  21 in total

1.  Differential Impact of Age Among Liver Transplant Candidates With and Without Hepatocellular Carcinoma.

Authors:  Giuseppe Cullaro; Jessica B Rubin; Neil Mehta; Jennifer C Lai
Journal:  Liver Transpl       Date:  2019-11-20       Impact factor: 5.799

2.  Estimating the Number of Patients Infected With Chronic HCV in the United States Who Meet Highest or High-Priority Treatment Criteria.

Authors:  Fujie Xu; Andrew J Leidner; Xin Tong; Scott D Holmberg
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

3.  Neighborhood Inequalities in Hepatitis C Mortality: Spatial and Temporal Patterns and Associated Factors.

Authors:  Mary M Ford; Payal S Desai; Gil Maduro; Fabienne Laraque
Journal:  J Urban Health       Date:  2017-10       Impact factor: 3.671

4.  What do primary care staff know and do about blood borne virus testing and care for migrant patients? A national survey.

Authors:  Rachel Roche; Ruth Simmons; Alison F Crawshaw; Pip Fisher; Manish Pareek; Will Morton; Theresa Shryane; Kristina Poole; Arpana Verma; Ines Campos-Matos; Sema Mandal
Journal:  BMC Public Health       Date:  2021-02-11       Impact factor: 3.295

5.  Uptake of and Factors Associated With Direct-acting Antiviral Therapy Among Patients in the Chronic Hepatitis Cohort Study, 2014 to 2015.

Authors:  Philip R Spradling; Jian Xing; Loralee B Rupp; Anne C Moorman; Stuart C Gordon; Mei Lu; Eyasu H Teshale; Joseph A Boscarino; Mark A Schmidt; Yihe G Daida; Scott D Holmberg
Journal:  J Clin Gastroenterol       Date:  2018-08       Impact factor: 3.062

Review 6.  Improving Healthcare Systems to Reduce Healthcare Disparities in Viral Hepatitis.

Authors:  Eric W Chak; Souvik Sarkar; Christopher Bowlus
Journal:  Dig Dis Sci       Date:  2016-05-27       Impact factor: 3.199

Review 7.  Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings.

Authors:  Anne C Moorman; Loralee B Rupp; Stuart C Gordon; Yuna Zhong; Jian Xing; Mei Lu; Joseph A Boscarino; Mark A Schmidt; Yihe G Daida; Eyasu H Teshale; Philip R Spradling; Scott D Holmberg
Journal:  Infect Dis Clin North Am       Date:  2018-06       Impact factor: 5.982

8.  Frequency of and Factors Associated with Receipt of Liver-Related Specialty Care Among Patients with Hepatitis C in the Chronic Hepatitis Cohort Study.

Authors:  Monique A Foster; Jian Xing; Anne C Moorman; Joseph Boscarino; Stuart C Gordon; Mei Lu; Loralee Rupp; Mark A Schmidt; Connie M Trinacty; Fujie Xu; Scott D Holmberg; Philip R Spradling
Journal:  Dig Dis Sci       Date:  2016-08-10       Impact factor: 3.199

9.  Occult liver disease burden: Analysis from a large general practitioners' database.

Authors:  Andrea Martini; Elena Ceranto; Angelo Gatta; Paolo Angeli; Patrizia Pontisso
Journal:  United European Gastroenterol J       Date:  2017-02-26       Impact factor: 4.623

10.  Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection.

Authors:  Prowpanga Udompap; Ajitha Mannalithara; Nae-Yun Heo; Donghee Kim; W Ray Kim
Journal:  J Hepatol       Date:  2016-01-22       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.